Literature DB >> 15805060

Imaging mass spectrometry: principles and potentials.

Pierre Chaurand1, Sarah A Schwartz, Michelle L Reyzer, Richard M Caprioli.   

Abstract

Direct tissue profiling and imaging mass spectrometry (MS) allow for detailed mapping of the complex protein pattern across a tissue sample. Utilization of these tools provides spatial information across a tissue section for target protein expression and can be used to correlate changes in expression levels with specific disease states or drug response. Protein patterns can be directly correlated to known histological regions within the tissue, allowing for the direct monitoring of proteins specific for morphological regions within a tissue sample. Profiling and imaging MS have been used to characterize multiple tissues, including human gliomas and lung cancers, as well as tumor response to specific therapeutics, suggesting the use of proteomic information in assessing disease progression as well as predicting patient response to specific treatments. This article discusses both the technology and methods involved in analyzing proteins directly from tissue samples as well as several MS applications, including profiling human tumors, characterizing protein differences between tumor grades, and monitoring protein changes due to drug therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805060     DOI: 10.1080/01926230590881862

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  43 in total

1.  From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry.

Authors:  Pierre Chaurand; Dale S Cornett; Peggi M Angel; Richard M Caprioli
Journal:  Mol Cell Proteomics       Date:  2010-08-23       Impact factor: 5.911

2.  Simultaneous detection of intracellular target and off-target binding of small molecule cancer drugs at nanomolar concentrations.

Authors:  Heike Glauner; Ivo R Ruttekolk; Kerrin Hansen; Ben Steemers; Yi-Da Chung; Frank Becker; Stefan Hannus; Roland Brock
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 3.  3D imaging by mass spectrometry: a new frontier.

Authors:  Erin H Seeley; Richard M Caprioli
Journal:  Anal Chem       Date:  2012-02-16       Impact factor: 6.986

Review 4.  Mass spectrometry-based proteomic profiling of lung cancer.

Authors:  Sebahat Ocak; Pierre Chaurand; Pierre P Massion
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

5.  Chapter 13: Imaging of cells and tissues with mass spectrometry: adding chemical information to imaging.

Authors:  Tyler A Zimmerman; Eric B Monroe; Kevin R Tucker; Stanislav S Rubakhin; Jonathan V Sweedler
Journal:  Methods Cell Biol       Date:  2008       Impact factor: 1.441

6.  Mass spectrometry imaging as a tool for surgical decision-making.

Authors:  David Calligaris; Isaiah Norton; Daniel R Feldman; Jennifer L Ide; Ian F Dunn; Livia S Eberlin; R Graham Cooks; Ferenc A Jolesz; Alexandra J Golby; Sandro Santagata; Nathalie Y Agar
Journal:  J Mass Spectrom       Date:  2013-11       Impact factor: 1.982

7.  Quantitative MALDI-MS(n) analysis of cocaine in the autopsied brain of a human cocaine user employing a wide isolation window and internal standards.

Authors:  Richard F Reich; Kasia Cudzilo; Joseph A Levisky; Richard A Yost
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-04       Impact factor: 3.109

8.  Enhancement of protein sensitivity for MALDI imaging mass spectrometry after chemical treatment of tissue sections.

Authors:  Erin H Seeley; Stacey R Oppenheimer; Deming Mi; Pierre Chaurand; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2008-04-08       Impact factor: 3.109

Review 9.  Label-free molecular imaging of the kidney.

Authors:  Boone M Prentice; Richard M Caprioli; Vincent Vuiblet
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

Review 10.  Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.

Authors:  Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.